相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
Kapil Tahlan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
Kathy Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval
H-G Eichler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro
Venkata M. Reddy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
Susan E. Dorman et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
Andreas H. Diacon et al.
LANCET (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
Robert S. Wallis et al.
PLOS ONE (2012)
Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
Jonna Idh et al.
PLOS ONE (2012)
Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
Robert S. Wallis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Sterilizing Activity of Novel TMC207-and PA-824-Containing Regimens in a Murine Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
Kuan Gandelman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response
Hans-Georg Eichler et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
Nicolas Veziris et al.
PLOS ONE (2011)
Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries
William A. Wells et al.
PLOS ONE (2011)
Evidence for Oxidative Stress and Defective Antioxidant Response in Guinea Pigs with Tuberculosis
Gopinath S. Palanisamy et al.
PLOS ONE (2011)
Is transcription of data on antiretroviral treatment from electronic to paper-based registers reliable in Malawi?
O. J. Gadabu et al.
PUBLIC HEALTH ACTION (2011)
Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
Andreas H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
Venkata M. Reddy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
Shadi Baniasadi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Pharmacokinetics and Whole-Blood Bactericidal Activity against Mycobacterium tuberculosis of Single Doses of PNU-100480 in Healthy Volunteers
Robert S. Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Biomarkers for tuberculosis disease activity, cure, and relapse
Robert S. Wallis et al.
LANCET INFECTIOUS DISEASES (2010)
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
Susan E. Dorman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture Conversion
John L. Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
Anna C. Haagsma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis
R. Rustomjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Persistence, not resistance, is the cause of loss of isoniazid effect
Robert S. Wallis et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Drug therapy of experimental tuberculosis (TB): Improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs
Boris V. Nikonenko et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth
Tawanda Gumbo et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Cost of treatment for multidrug-resistant tuberculosis in South Korea
Young Ae Kang et al.
RESPIROLOGY (2006)
Interspecies pharmacokinetics and in vitro metabolism of SQ109
L Jia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Lack of activity of orally administered clofazimine against intracellular Mycobacterium tuberculosis in whole-blood culture
E Janulionis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis
R Dietze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum:: Potential surrogate marker in tuberculosis chemotherapy trials
RS Wallis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)